[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NZ507983A - A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof - Google Patents

A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Info

Publication number
NZ507983A
NZ507983A NZ507983A NZ50798399A NZ507983A NZ 507983 A NZ507983 A NZ 507983A NZ 507983 A NZ507983 A NZ 507983A NZ 50798399 A NZ50798399 A NZ 50798399A NZ 507983 A NZ507983 A NZ 507983A
Authority
NZ
New Zealand
Prior art keywords
amino acid
polypeptide
truncate
binding protein
choline binding
Prior art date
Application number
NZ507983A
Other languages
English (en)
Inventor
Elaine I Tuomanen
H Robert Masure
Theresam Wizemann
Leslie Sydnor Johnson
Scott Koenig
Original Assignee
St
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/056,019 external-priority patent/US6858706B2/en
Application filed by St filed Critical St
Publication of NZ507983A publication Critical patent/NZ507983A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ507983A 1998-04-07 1999-04-07 A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof NZ507983A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8087898P 1998-04-07 1998-04-07
US09/056,019 US6858706B2 (en) 1998-04-07 1998-04-07 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
PCT/US1999/007669 WO1999051188A2 (en) 1998-04-07 1999-04-07 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Publications (1)

Publication Number Publication Date
NZ507983A true NZ507983A (en) 2004-03-26

Family

ID=26734874

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ507983A NZ507983A (en) 1998-04-07 1999-04-07 A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Country Status (14)

Country Link
JP (1) JP4739521B2 (xx)
KR (1) KR100638503B1 (xx)
CN (1) CN1191851C (xx)
AU (2) AU3479699A (xx)
BR (1) BR9909910A (xx)
CA (1) CA2326388C (xx)
HU (1) HUP0102306A3 (xx)
IL (1) IL138939A0 (xx)
MX (1) MXPA00009899A (xx)
NO (1) NO20005081L (xx)
NZ (1) NZ507983A (xx)
PL (1) PL193132B1 (xx)
TR (1) TR200003498T2 (xx)
WO (1) WO1999051188A2 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
PT1968631E (pt) 2005-12-22 2015-07-20 Glaxosmithkline Biolog Sa Vacina
US9610340B2 (en) 2007-06-26 2017-04-04 Glaxosmithkline Biologicals, S.A. Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates
CN102099052A (zh) 2008-04-16 2011-06-15 葛兰素史密丝克莱恩生物有限公司 疫苗
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
AU2012257771C1 (en) 2011-05-17 2015-12-03 Glaxosmithkline Biologicals S.A. Vaccine against Streptococcus pneumoniae
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
DE69735715T2 (de) * 1996-05-01 2007-03-29 The Rockefeller University Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird
CA2269663A1 (en) * 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae antigens and vaccines
WO1998021337A2 (en) * 1996-11-12 1998-05-22 Regents Of The University Of Minnesota C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
IL138798A0 (en) * 1998-04-07 2001-10-31 Medimmune Inc Vaccines and antibodies against bacterial pneumococcal infection

Also Published As

Publication number Publication date
PL347946A1 (en) 2002-04-22
MXPA00009899A (es) 2002-05-08
JP4739521B2 (ja) 2011-08-03
IL138939A0 (en) 2001-11-25
AU3479699A (en) 1999-10-25
KR100638503B1 (ko) 2006-10-26
CN1191851C (zh) 2005-03-09
TR200003498T2 (tr) 2001-10-22
NO20005081D0 (no) 2000-10-09
HUP0102306A3 (en) 2008-04-28
NO20005081L (no) 2000-12-06
AU3479799A (en) 1999-10-25
WO1999051188A9 (en) 2000-10-12
KR20010052244A (ko) 2001-06-25
AU764811B2 (en) 2003-08-28
WO1999051188A3 (en) 2001-04-19
CA2326388C (en) 2014-02-04
WO1999051188A2 (en) 1999-10-14
PL193132B1 (pl) 2007-01-31
BR9909910A (pt) 2002-01-15
HUP0102306A1 (hu) 2001-09-28
JP2002516662A (ja) 2002-06-11
CN1342088A (zh) 2002-03-27
CA2326388A1 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
CA2230885A1 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
BR0015137A (pt) Peptìdeos antigênicos de neisseria
CA2253636A1 (en) Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
HRP980203B1 (en) Modified tnf "alpha" molecules, dna encoding such modified tnf "alpha" molecules and vaccines comprising such modified tnf "alpha" molecules and dna
EP2118128B1 (en) Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
CA2014033A1 (en) Compositions and treatments for pneumonia in animals
NZ507983A (en) A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
ATE268384T1 (de) Analog von haemophilus hin47 mit verminderter protease aktivität
BR9812240A (pt) Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica
NZ333203A (en) Tumour antigen proteins, genes thereof, and tumour antigen peptides
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
WO2000012535A3 (en) Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
WO2000029434A3 (en) PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
CA2002833A1 (en) Interferon-gamma binding proteins
AU5776799A (en) Modified hcv peptide vaccines
JP2004513615A5 (xx)
KR102369146B1 (ko) 코로나 백신 제형
EP0770137A4 (en) IMPROVEMENTS IN PROTEIN PRODUCTION IN HOST CELLS
WO1998022580A3 (en) Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
PL347943A1 (en) Moraxella catarrhalis basb034 polypeptides and uses thereof
WO2001098355A3 (en) Cgi-69 compositions and methods of use
WO2003022867A3 (en) Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag
WO2002010379B1 (en) Modified cea and uses thereof
DE60223232D1 (de) Mucinpeptid mit immunstärkenden eigenschaften

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired